124 related articles for article (PubMed ID: 31812072)
1. Reprogramming of human Peripheral Blood Mononuclear Cell (PBMC) from a Chinese patient suffering Duchenne muscular dystrophy to iPSC line (SDQLCHi007-A) carrying deletion of 49-50 exons in the DMD gene.
Guan J; Liu X; Zhang H; Yang X; Ma Y; Li Y; Gai Z; Liu Y
Stem Cell Res; 2020 Jan; 42():101666. PubMed ID: 31812072
[TBL] [Abstract][Full Text] [Related]
2. Establishment of a Duchenne muscular dystrophy patient-derived induced pluripotent stem cell line carrying a deletion of exons 51-53 of the dystrophin gene (CCMi003-A).
Rovina D; Castiglioni E; Farini A; Bellichi M; Gervasini C; Paganini S; Di Segni M; Santoro R; Torrente Y; Pompilio G; Gowran A
Stem Cell Res; 2019 Oct; 40():101544. PubMed ID: 31465894
[TBL] [Abstract][Full Text] [Related]
3. Reprogramming of dermal fibroblasts from a Duchenne muscular dystrophy patient carrying a deletion of exons 45-50 into an induced pluripotent stem cell line (CCMi005-A).
Rovina D; Castiglioni E; Mallia S; Rabino M; Farini A; Belicchi M; Di Giuseppe G; Gervasini C; Torrente Y; Pompilio G; Gowran A
Stem Cell Res; 2022 Oct; 64():102889. PubMed ID: 35961103
[TBL] [Abstract][Full Text] [Related]
4. Establishment of a human iPSC line XMDYYYi001-A from a patient with Becker muscular dystrophy harboring duplications of exons 2-19 in dystrophin gene.
Wang D; Lin J; Jin M; Wang N
Stem Cell Res; 2021 May; 53():102298. PubMed ID: 33799273
[TBL] [Abstract][Full Text] [Related]
5. Derivation of the Duchenne muscular dystrophy patient-derived induced pluripotent stem cell line lacking DMD exons 49 and 50 (CCMi001DMD-A-3, ∆49, ∆50).
Spaltro G; Vigorelli V; Casalnuovo F; Spinelli P; Castiglioni E; Rovina D; Paganini S; Di Segni M; Nigro P; Gervasini C; Pompilio G; Gowran A
Stem Cell Res; 2017 Dec; 25():128-131. PubMed ID: 29127875
[TBL] [Abstract][Full Text] [Related]
6. Direct Reprogramming of Human DMD Fibroblasts into Myotubes for In Vitro Evaluation of Antisense-Mediated Exon Skipping and Exons 45-55 Skipping Accompanied by Rescue of Dystrophin Expression.
Lee JJA; Saito T; Duddy W; Takeda S; Yokota T
Methods Mol Biol; 2018; 1828():141-150. PubMed ID: 30171539
[TBL] [Abstract][Full Text] [Related]
7. Generation of two genomic-integration-free DMD iPSC lines with mutations affecting all dystrophin isoforms and potentially amenable to exon-skipping.
Ferrari G; Muntoni F; Tedesco FS
Stem Cell Res; 2020 Mar; 43():101688. PubMed ID: 32087527
[TBL] [Abstract][Full Text] [Related]
8. Generation and characterization of an induced pluripotent stem cell line (ZSYYDNi001-A) from a patient with Duchenne muscular dystrophy carrying exon 51 deletion in the DMD gene.
Wang L; Li H; Li Y; Xu M; Lin J; Liao Z; Pei Z; Zhang C
Stem Cell Res; 2021 Oct; 56():102553. PubMed ID: 34619646
[TBL] [Abstract][Full Text] [Related]
9. Generation of Duchenne muscular dystrophy patient-specific induced pluripotent stem cell line lacking exons 45-50 of the dystrophin gene (IITi001-A).
Eisen B; Ben Jehuda R; Cuttitta AJ; Mekies LN; Reiter I; Ramchandren S; Arad M; Michele DE; Binah O
Stem Cell Res; 2018 May; 29():111-114. PubMed ID: 29653394
[TBL] [Abstract][Full Text] [Related]
10. Generation and characterization of an induced pluripotent stem cell line (FJMUNi001-A) from a patient with Duchenne muscular dystrophy carrying c.4518 + 512 T > A variant in the DMD gene.
Jin M; Wang D; Li G; Lin J; Lin X; Wang N
Stem Cell Res; 2022 Apr; 60():102718. PubMed ID: 35247844
[TBL] [Abstract][Full Text] [Related]
11. Generation of three Duchenne Muscular Dystrophy patient-specific induced pluripotent stem cell lines DMD_YoTaz_PhyMedEXp, DMD_RaPer_PhyMedEXp, DMD_OuMen_PhyMedEXp (INSRMi008-A, INSRMi009-A and INSRMi010-A).
Souidi M; Amédro P; Meyer P; Desprat R; Lemaître JM; Rivier F; Lacampagne A; Meli AC
Stem Cell Res; 2020 Dec; 49():102094. PubMed ID: 33246213
[TBL] [Abstract][Full Text] [Related]
12. Characterization of deletion breakpoints in patients with dystrophinopathy carrying a deletion of exons 45-55 of the Duchenne muscular dystrophy (DMD) gene.
Miyazaki D; Yoshida K; Fukushima K; Nakamura A; Suzuki K; Sato T; Takeda S; Ikeda S
J Hum Genet; 2009 Feb; 54(2):127-30. PubMed ID: 19158820
[TBL] [Abstract][Full Text] [Related]
13. Screening of dystrophin gene deletions in Malaysian patients with Duchenne muscular dystrophy.
Marini M; Salmi AA; Watihayati MS; SMardziah MD; Zahri MK; Hoh BP; Ankathil R; Lai PS; Zilfalil BA
Med J Malaysia; 2008 Mar; 63(1):31-4. PubMed ID: 18935728
[TBL] [Abstract][Full Text] [Related]
14. Generation of induced pluripotent stem cells from a Becker muscular dystrophy patient carrying a deletion of exons 45-55 of the dystrophin gene (CCMi002BMD-A-9 ∆45-55).
Gowran A; Spaltro G; Casalnuovo F; Vigorelli V; Spinelli P; Castiglioni E; Rovina D; Paganini S; Di Segni M; Gervasini C; Nigro P; Pompilio G
Stem Cell Res; 2018 Apr; 28():21-24. PubMed ID: 29414413
[TBL] [Abstract][Full Text] [Related]
15. Generation of three Duchenne muscular dystrophy patient-derived induced pluripotent stem cell (iPSC) lines ICGi002-A, ICGi002-B and ICGi002-C.
Valetdinova KR; Maretina MA; Vyatkin YV; Perepelkina MP; Egorova AA; Baranov VS; Kiselev AV; Gershovich PM; Zakian SM
Stem Cell Res; 2020 Oct; 48():101941. PubMed ID: 32777771
[TBL] [Abstract][Full Text] [Related]
16. Generation of the Becker muscular dystrophy patient derived induced pluripotent stem cell line carrying the DMD splicing mutation c.1705-8 T>C.
Rovina D; Castiglioni E; Niro F; Farini A; Belicchi M; Di Fede E; Gervasini C; Paganini S; Di Segni M; Torrente Y; Santoro R; Pompilio G; Gowran A
Stem Cell Res; 2020 May; 45():101819. PubMed ID: 32348941
[TBL] [Abstract][Full Text] [Related]
17. 'Double trouble': diagnostic challenges in Duchenne muscular dystrophy in patients with an additional hereditary skeletal dysplasia.
Donkervoort S; Schindler A; Tesi-Rocha C; Schreiber A; Leach ME; Dastgir J; Hu Y; Mankodi A; Wagner KR; Friedman NR; Bönnemann CG
Neuromuscul Disord; 2013 Dec; 23(12):955-61. PubMed ID: 24070816
[TBL] [Abstract][Full Text] [Related]
18. In Vitro Multiexon Skipping by Antisense PMOs in Dystrophic Dog and Exon 7-Deleted DMD Patient.
Nakamura A; Aoki Y; Tsoumpra M; Yokota T; Takeda S
Methods Mol Biol; 2018; 1828():151-163. PubMed ID: 30171540
[TBL] [Abstract][Full Text] [Related]
19. Duchenne muscular dystrophy: a clinical, histopathological and genetic study at a neurology tertiary care center in Southern India.
Swaminathan B; Shubha GN; Shubha D; Murthy AR; Kiran Kumar HB; Shylashree S; Gayathri N; Jamuna R; Jain S; Purushottam M; Nalini A
Neurol India; 2009; 57(6):734-8. PubMed ID: 20139501
[TBL] [Abstract][Full Text] [Related]
20. A novel canine model for Duchenne muscular dystrophy (DMD): single nucleotide deletion in DMD gene exon 20.
Mata López S; Hammond JJ; Rigsby MB; Balog-Alvarez CJ; Kornegay JN; Nghiem PP
Skelet Muscle; 2018 May; 8(1):16. PubMed ID: 29843823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
